×
About 25,036 results

ALLMedicine™ Respiratory Failure Center

Research & Reviews  12,345 results

Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoi...
https://doi.org/10.1093/rheumatology/keaa327
Rheumatology (Oxford, England); Ibfelt EH, Jacobsen RK et. al.

Aug 11th, 2020 - MTX is the most commonly recommended DMARD for first-line treatment of RA, however, it has been hypothesized to cause lung disease as an adverse effect. We investigated the risk of interstitial lung disease (ILD) and acute and chronic respiratory ...

Predictors for long-term mortality in COPD patients requiring non-invasive positive pre...
https://doi.org/10.1111/crj.13251
The Clinical Respiratory Journal; Sprooten RTM, Rohde GGU et. al.

Aug 11th, 2020 - The effectiveness of non-invasive mechanical ventilation (NIV) in the management of COPD patients suffering from acute respiratory failure (ARF) as a consequence of exacerbation of the disease, is well-established. However, data on long-term outco...

Development and validation of a prediction model for severe respiratory failure in hosp...
https://doi.org/10.1016/j.cmi.2020.08.003
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases; Bartoletti M, Giannella M et. al.

Aug 11th, 2020 - We aimed to develop and validate a risk score to predict severe respiratory failure (SRF) among patients hospitalized with coronavirus disease-2019 (COVID-19). We performed a multicentre cohort study among hospitalized (>24 hours) patients diagnos...

Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment ...
https://doi.org/10.1055/s-0040-1708837
Seminars in Respiratory and Critical Care Medicine; Gupta N, Haley R et. al.

Aug 11th, 2020 - Patients who suffer from chronic obstructive pulmonary disease (COPD) often experience deterioration of baseline respiratory symptoms, acute exacerbations of COPD (AECOPD), that become more frequent with disease progression. Based on symptom sever...

NEK1 and GRN mutations coexist in a sporadic Chinese Hui descent ALS patient.
https://doi.org/10.1080/21678421.2020.1779301
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; Zhang K, Lu Y et. al.

Aug 10th, 2020 - We describe a sporadic amyotrophic lateral sclerosis (ALS) patient who presented rapid progress of muscle weakness and died of respiratory failure one and a half years after onset. Genetic analysis revealed a novel ALS-causing gene NEK1 nonsense m...

see more →

Guidelines  41 results

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360514
Respiration; International Review of Thoracic Diseases; Pfeifer M, Ewig S et. al.

Jun 21st, 2020 - Against the background of the pandemic caused by infection with the SARS-CoV-2 virus, the German Respiratory Society has appointed experts to develop therapy strategies for COVID-19 patients with acute respiratory failure (ARF). Here we present ke...

Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274948
Chest Lamb CR, Desai NR et. al.

Jun 8th, 2020 - The role of tracheostomy during the COVID-19 pandemic remains unknown. The goal of this consensus statement is to examine the current evidence for performing tracheostomy in patients with respiratory failure from COVID-19 and offer guidance to phy...

Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic D...
https://doi.org/10.1159/000505634
Respiration; International Review of Thoracic Diseases; Boentert M, Cao M et. al.

Apr 16th, 2020 - Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects approximately 1 in 2,500 individuals globally [Ashizawa et al.: Neurol Clin Pract 2018;8(6):507-20]. In patients with DM1, respiratory muscle weakness frequently...

Acute subglottic laryngitis. Etiology, epidemiology, pathogenesis and clinical picture.
https://doi.org/10.5603/ARM.2019.0056
Advances in Respiratory Medicine; Mazurek H, Bręborowicz A et. al.

Nov 4th, 2019 - In about 3% of children, viral infections of the airways that develop in early childhood lead to narrowing of the laryngeal lumen in the subglottic region resulting in symptoms such as hoarseness, abarking cough, stridor, and dyspnea. These infect...

Predicting the Risk of Postoperative Pulmonary Complications
https://www.aafp.org/afp/2019/1015/p499.html
American Family Physician;

Oct 14th, 2019 - The incidence of pulmonary complications following major surgery is estimated to be 1% to 23%, with the risk varying based on patient factors and the type of surgery.1 Postoperative pulmonary complications include pneumonia, tracheobronchitis, pul...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  12,435 results

Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoi...
https://doi.org/10.1093/rheumatology/keaa327
Rheumatology (Oxford, England); Ibfelt EH, Jacobsen RK et. al.

Aug 11th, 2020 - MTX is the most commonly recommended DMARD for first-line treatment of RA, however, it has been hypothesized to cause lung disease as an adverse effect. We investigated the risk of interstitial lung disease (ILD) and acute and chronic respiratory ...

Predictors for long-term mortality in COPD patients requiring non-invasive positive pre...
https://doi.org/10.1111/crj.13251
The Clinical Respiratory Journal; Sprooten RTM, Rohde GGU et. al.

Aug 11th, 2020 - The effectiveness of non-invasive mechanical ventilation (NIV) in the management of COPD patients suffering from acute respiratory failure (ARF) as a consequence of exacerbation of the disease, is well-established. However, data on long-term outco...

Development and validation of a prediction model for severe respiratory failure in hosp...
https://doi.org/10.1016/j.cmi.2020.08.003
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases; Bartoletti M, Giannella M et. al.

Aug 11th, 2020 - We aimed to develop and validate a risk score to predict severe respiratory failure (SRF) among patients hospitalized with coronavirus disease-2019 (COVID-19). We performed a multicentre cohort study among hospitalized (>24 hours) patients diagnos...

Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment ...
https://doi.org/10.1055/s-0040-1708837
Seminars in Respiratory and Critical Care Medicine; Gupta N, Haley R et. al.

Aug 11th, 2020 - Patients who suffer from chronic obstructive pulmonary disease (COPD) often experience deterioration of baseline respiratory symptoms, acute exacerbations of COPD (AECOPD), that become more frequent with disease progression. Based on symptom sever...

NEK1 and GRN mutations coexist in a sporadic Chinese Hui descent ALS patient.
https://doi.org/10.1080/21678421.2020.1779301
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; Zhang K, Lu Y et. al.

Aug 10th, 2020 - We describe a sporadic amyotrophic lateral sclerosis (ALS) patient who presented rapid progress of muscle weakness and died of respiratory failure one and a half years after onset. Genetic analysis revealed a novel ALS-causing gene NEK1 nonsense m...

see more →

News  207 results

Fulcrum Therapeutics begins trial of muscle disorder drug for COVID-19 patients
https://www.reuters.com/article/us-health-coronavirus-fulcrum/fulcrum-therapeutics-begins-trial-of-muscle-disorder-drug-for-covid-19-patients-idUSKBN23V1MJ

Jun 24th, 2020 - (Reuters) - Fulcrum Therapeutics Inc said on Wednesday it has started the late-stage trial of its experimental muscle disorder drug, losmapimod, in adults hospitalized with COVID-19. The company in-licensed losmapimod from GlaxoSmithKline Plc last...

UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties
https://www.reuters.com/article/us-health-coronavirus-britain-ibuprofen/uk-doctors-to-trial-ibuprofen-in-covid-19-patients-with-breathing-difficulties-idUSKBN23A1DV

Jun 3rd, 2020 - LONDON (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19. The trial involves a particular formulation of ibuprofen, which re...

FDA to allow alternative respiratory devices to treat COVID-19
https://www.mdedge.com/internalmedicine/article/219591/coronavirus-updates/fda-allow-alternative-respiratory-devices-treat?channel=38029
Gregory Twachtman

Mar 25th, 2020 - The Food and Drug Administration identified a number of medical devices that can be used to help treat patients suffering from COVID-19 if ventilators are not available. “Whenever possible, health care facilities should use FDA-cleared conventiona.

Azerbaijan reports first coronavirus death
https://www.reuters.com/article/us-health-coronavirus-azerbaijan/azerbaijan-reports-first-coronavirus-death-idUSKBN20Z29V

Mar 12th, 2020 - BAKU (Reuters) - An Azeri woman who was quarantined after returning from Iran has died from coronavirus, Azerbaijan’s first death from the outbreak, the country’s emergency crisis center said on Thursday. The woman, who was born in 1969, was found...

Moldova reports first coronavirus case
https://www.reuters.com/article/us-health-coronavirus-moldova/moldova-reports-first-coronavirus-case-idUSKBN20V08U

Mar 8th, 2020 - CHISINAU (Reuters) - Moldova has reported its first confirmed coronavirus case, the Moldovan health ministry said late on Saturday. The 48-year-old woman was hospitalized on Saturday after she arrived from Italy, the ministry said in a statement. ...

see more →

Patient Education  4 results see all →